From a technical standpoint, tricuspid valve repair/replacement is not complex and can often be conducted on a warm, beating, perfused heart. There are only a few large series of operations done for isolated TR, in contrast to the more extensive literature on mitral regurgitation. Large series were published that included patients operated on primarily for left-sided cardiac pathologies but who also underwent incidental tricuspid valve procedure due to a range of tricuspid valve pathologies.[28]Guenther T, Noebauer C, Mazzitelli D, et al. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg. 2008 Aug;34(2):402-9.
https://academic.oup.com/ejcts/article/34/2/402/413606
http://www.ncbi.nlm.nih.gov/pubmed/18579403?tool=bestpractice.com
[39]Bernal JM, Ponton A, Diaz B, et al. Surgery for rheumatic tricuspid valve disease: a 30-year experience. J Thorac Cardiovasc Surg. 2008 Aug;136(2):476-81.
https://www.jtcvs.org/article/S0022-5223(08)00669-7/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/18692660?tool=bestpractice.com
Several principles of treatment can be gleaned from the available literature on TR and tricuspid valve surgery.
Long-term outcome: all patients
Patients who require tricuspid valve operation constitute a high-risk group. Thirty-day mortality in patients who received concomitant tricuspid valve procedure in addition to the correction of other cardiac pathologies has been shown to be as high as 19%.[28]Guenther T, Noebauer C, Mazzitelli D, et al. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg. 2008 Aug;34(2):402-9.
https://academic.oup.com/ejcts/article/34/2/402/413606
http://www.ncbi.nlm.nih.gov/pubmed/18579403?tool=bestpractice.com
The high operative mortality is representative of the underlying cardiac pathology and is not necessarily reversed with successful operation. Outcomes mostly depend on concomitant cardiac pathologies.
Follow-up of patients at 30 years showed an actuarial survival of 12%.[39]Bernal JM, Ponton A, Diaz B, et al. Surgery for rheumatic tricuspid valve disease: a 30-year experience. J Thorac Cardiovasc Surg. 2008 Aug;136(2):476-81.
https://www.jtcvs.org/article/S0022-5223(08)00669-7/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/18692660?tool=bestpractice.com
The numbers have been representative of what amounts to an incurable valve disease.
Long-term outcome: recent advances
Outcomes related to a more recent year of operation suggest improved results. Operation before 1989 is a significant predictor of late death: 66% for operation before 1989 and 32% for operation after 1989.[39]Bernal JM, Ponton A, Diaz B, et al. Surgery for rheumatic tricuspid valve disease: a 30-year experience. J Thorac Cardiovasc Surg. 2008 Aug;136(2):476-81.
https://www.jtcvs.org/article/S0022-5223(08)00669-7/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/18692660?tool=bestpractice.com
The improved outcomes certainly represent important clinical, diagnostic, and surgical advances that have taken place. In addition, a better understanding of TR and its clinical presentation allow earlier diagnosis and treatment. Patients are much better served with operation before significant end-organ damage (i.e., cardiac cirrhosis) develops.
Repair versus replacement
Tricuspid valve repair is associated with better perioperative and long-term outcomes than valve replacement.[28]Guenther T, Noebauer C, Mazzitelli D, et al. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. Eur J Cardiothorac Surg. 2008 Aug;34(2):402-9.
https://academic.oup.com/ejcts/article/34/2/402/413606
http://www.ncbi.nlm.nih.gov/pubmed/18579403?tool=bestpractice.com
[29]Singh SK, Tang GH, Maganti MD, et al. Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. Ann Thorac Surg. 2006 Nov;82(5):1735-41.
http://www.ncbi.nlm.nih.gov/pubmed/17062239?tool=bestpractice.com
The authors of this monograph favor valve repair in patients with functional TR with relatively preserved heart function and normal pulmonary artery pressures.
Durability of valve repair
There is an important point to be made with respect to tricuspid valve repair: it does not always give a durable result.[29]Singh SK, Tang GH, Maganti MD, et al. Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. Ann Thorac Surg. 2006 Nov;82(5):1735-41.
http://www.ncbi.nlm.nih.gov/pubmed/17062239?tool=bestpractice.com
Reoperation for failure of tricuspid valve repair is associated with high mortality, both perioperatively and in the long term.[40]Bernal JM, Morales D, Revuelta C, et al. Reoperations after tricuspid valve repair. J Thorac Cardiovasc Surg. 2005 Aug;130(2):498-503.
http://www.jtcvsonline.org/article/PIIS0022522305001182/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/16077419?tool=bestpractice.com
Risk factors for failure of valve repair
Risk factors for failure of tricuspid valve repair failure that have been investigated include:
Left and right ventricular function.[41]Fukuda S, Gillinov AM, McCarthy PM, et al. Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty. Circulation. 2006 Jul 4;114(1 Suppl):I582-7.
https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.105.001305
http://www.ncbi.nlm.nih.gov/pubmed/16820642?tool=bestpractice.com
Increased right and left ventricular pressures.[41]Fukuda S, Gillinov AM, McCarthy PM, et al. Determinants of recurrent or residual functional tricuspid regurgitation after tricuspid annuloplasty. Circulation. 2006 Jul 4;114(1 Suppl):I582-7.
https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.105.001305
http://www.ncbi.nlm.nih.gov/pubmed/16820642?tool=bestpractice.com
However, it has been shown that there is no difference with respect to freedom from valve-related mortality and from tricuspid valve reoperation.[29]Singh SK, Tang GH, Maganti MD, et al. Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. Ann Thorac Surg. 2006 Nov;82(5):1735-41.
http://www.ncbi.nlm.nih.gov/pubmed/17062239?tool=bestpractice.com
Association with mitral valve regurgitation
Mitral regurgitation often results in secondary tricuspid annular dilation that may or may not be accompanied by TR. The resultant dilation is an ongoing disease process that can lead to severe TR and worse outcome if patients are not treated with concomitant tricuspid valve annuloplasty.[34]Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005 Jan;79(1):127-32.
http://www.ncbi.nlm.nih.gov/pubmed/15620928?tool=bestpractice.com
[42]Matsunaga A, Duran CM. Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation. 2005 Aug 30;112(9 Suppl):I453-7.
https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.104.524421
http://www.ncbi.nlm.nih.gov/pubmed/16159862?tool=bestpractice.com
The authors of this monograph would recommend tricuspid annuloplasty in patients when the annulus is significantly dilated.[34]Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005 Jan;79(1):127-32.
http://www.ncbi.nlm.nih.gov/pubmed/15620928?tool=bestpractice.com
Implications of restoration of sinus rhythm
TR is common in patients undergoing mitral valve surgery, and atrial fibrillation may cause progression of TR. A case-control study found that continued atrial fibrillation after mitral valve surgery may predispose a patient to progression of TR, and this progression may be prevented through correction of atrial fibrillation with the Maze procedure.[43]Stulak JM, Schaff HV, Dearani JA, et al. Restoration of sinus rhythm by the Maze procedure halts progression of tricuspid regurgitation after mitral surgery. Ann Thorac Surg. 2008 Jul;86(1):40-4.
http://www.ncbi.nlm.nih.gov/pubmed/18573396?tool=bestpractice.com